UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000004118 |
|---|---|
| Receipt number | R000004951 |
| Scientific Title | A phase I/II study of Bevacizumab combined with Cisplatin and Pemetrexed for Patients with Advanced Non-Squamous Non-Small-Cell Lung Cancer |
| Date of disclosure of the study information | 2010/08/27 |
| Last modified on | 2022/09/05 17:27:53 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/08/27 22:41:19 | ||
| 2 | Update | 2011/11/07 14:35:56 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 3 | Update | 2013/09/27 15:18:58 | Email Email1 |
|
| 4 | Update | 2022/09/05 17:18:37 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Organization Organization Organization Address Address Tel |
|
| 5 | Update | 2022/09/05 17:21:53 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date |
|
| 6 | Update | 2022/09/05 17:27:53 | Number of participants that the trial has enrolled |
